Imperva (NYSE: IMPV) reported Q4 EPS of $0.20, $0.05 better than the analyst estimate of $0.15. Revenue for the quarter came in at $72.7 million versus the consensus estimate of $68.16 million.

GUIDANCE:

Imperva sees Q1 2016 EPS of ($0.26)-($0.32), versus the consensus of ($0.12). Imperva sees Q1 2016 revenue of $58-60 million, versus the consensus of $59.83 million.

Imperva sees FY2016 EPS of $0.17-$0.23, versus the consensus of $0.31. Imperva sees FY2016 revenue of $302-307 million, versus the consensus of $290.23 million.

For earnings history and earnings-related data on Imperva (IMPV) click here.